Clinical Trial Update: LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for landiolol (LANdiolol) to avoid tachycardia in patients at cardiovascular risk undergoing major non-cardiac surgery; not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Perioperative Myocardial Injury, Autonomic Dysfunction | Phase 4 | Status: NOT_YET_RECRUITING